PTK787/ZK 222584
Term · Oncology and biomedicine · MLC-T-ONC-007073
A substance that is being studied in the treatment of cancer. It belongs to the families of drugs called protein tyrosine kinase inhibitors and VEGF receptor kinase inhibitors. Also called vatalanib.
| Identifier | MLC-T-ONC-007073 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | vatalanib |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-007073",
"term": "PTK787/ZK 222584",
"field": "Oncology and biomedicine",
"definition": "A substance that is being studied in the treatment of cancer. It belongs to the families of drugs called protein tyrosine kinase inhibitors and VEGF receptor kinase inhibitors. Also called vatalanib.",
"synonyms": [
"vatalanib"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/ptk787-zk-222584/"
}
Record 13,853 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.